Literature DB >> 35188103

STAT3-mediated allelic imbalance of novel genetic variant Rs1047643 and B-cell-specific super-enhancer in association with systemic lupus erythematosus.

Yanfeng Zhang1, Kenneth Day2, Devin M Absher1.   

Abstract

Mapping of allelic imbalance (AI) at heterozygous loci has the potential to establish links between genetic risk for disease and biological function. Leveraging multi-omics data for AI analysis and functional annotation, we discovered a novel functional risk variant rs1047643 at 8p23 in association with systemic lupus erythematosus (SLE). This variant displays dynamic AI of chromatin accessibility and allelic expression on FDFT1 gene in B cells with SLE. We further found a B-cell restricted super-enhancer (SE) that physically contacts with this SNP-residing locus, an interaction that also appears specifically in B cells. Quantitative analysis of chromatin accessibility and DNA methylation profiles further demonstrated that the SE exhibits aberrant activity in B cell development with SLE. Functional studies identified that STAT3, a master factor associated with autoimmune diseases, directly regulates both the AI of risk variant and the activity of SE in cultured B cells. Our study reveals that STAT3-mediated SE activity and cis-regulatory effects of SNP rs1047643 at 8p23 locus are associated with B cell deregulation in SLE.
© 2022, Zhang et al.

Entities:  

Keywords:  STAT3; allelic imbalance; b-lymphocyte; chromatin accessibility; computational biology; genetics; genomics; human; super-enhancer; systemic lupus erythematosus; systems biology

Mesh:

Substances:

Year:  2022        PMID: 35188103      PMCID: PMC8884724          DOI: 10.7554/eLife.72837

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  55 in total

Review 1.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

2.  Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.

Authors:  Stephen C J Parker; Michael L Stitzel; D Leland Taylor; Jose Miguel Orozco; Michael R Erdos; Jennifer A Akiyama; Kelly Lammerts van Bueren; Peter S Chines; Narisu Narisu; Brian L Black; Axel Visel; Len A Pennacchio; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

4.  Skewed allelic expression on X chromosome associated with aberrant expression of XIST on systemic lupus erythematosus lymphocytes.

Authors:  Yanfeng Zhang; Xinrui Li; Andrew Gibson; Jeffrey Edberg; Robert P Kimberly; Devin M Absher
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

5.  Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype.

Authors:  Daehwan Kim; Joseph M Paggi; Chanhee Park; Christopher Bennett; Steven L Salzberg
Journal:  Nat Biotechnol       Date:  2019-08-02       Impact factor: 54.908

Review 6.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

7.  Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development.

Authors:  Kaoru Saijo; Christian Schmedt; I-Hsin Su; Hajime Karasuyama; Clifford A Lowell; Michael Reth; Takahiro Adachi; Alina Patke; Angela Santana; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2003-02-03       Impact factor: 25.606

8.  GWAS Central: a comprehensive resource for the discovery and comparison of genotype and phenotype data from genome-wide association studies.

Authors:  Tim Beck; Tom Shorter; Anthony J Brookes
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

9.  Systematic identification of trans eQTLs as putative drivers of known disease associations.

Authors:  Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight
Journal:  Nat Genet       Date:  2013-09-08       Impact factor: 38.330

10.  Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival.

Authors:  Brian Van Ness; Christine Ramos; Majda Haznadar; Antje Hoering; Jeff Haessler; John Crowley; Susanna Jacobus; Martin Oken; Vincent Rajkumar; Philip Greipp; Bart Barlogie; Brian Durie; Michael Katz; Gowtham Atluri; Gang Fang; Rohit Gupta; Michael Steinbach; Vipin Kumar; Richard Mushlin; David Johnson; Gareth Morgan
Journal:  BMC Med       Date:  2008-09-08       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.